Identification of HOXB8 and KLK11 expression levels as potential biomarkers to predict the effects of FOLFOX4 chemotherapy.
about
Identifying clinically relevant drug resistance genes in drug-induced resistant cancer cell lines and post-chemotherapy tissuesKnockdown of KLK11 inhibits cell proliferation and increases oxaliplatin sensitivity in human colorectal cancer.Immunological landscape of consensus clusters in colorectal cancer.
P2860
Identification of HOXB8 and KLK11 expression levels as potential biomarkers to predict the effects of FOLFOX4 chemotherapy.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Identification of HOXB8 and KL ...... fects of FOLFOX4 chemotherapy.
@en
Identification of HOXB8 and KL ...... fects of FOLFOX4 chemotherapy.
@nl
type
label
Identification of HOXB8 and KL ...... fects of FOLFOX4 chemotherapy.
@en
Identification of HOXB8 and KL ...... fects of FOLFOX4 chemotherapy.
@nl
prefLabel
Identification of HOXB8 and KL ...... fects of FOLFOX4 chemotherapy.
@en
Identification of HOXB8 and KL ...... fects of FOLFOX4 chemotherapy.
@nl
P2093
P2860
P356
P1433
P1476
Identification of HOXB8 and KL ...... fects of FOLFOX4 chemotherapy.
@en
P2093
P2860
P304
P356
10.2217/FON.13.25
P407
P577
2013-05-01T00:00:00Z